Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00268632
Status:
COMPLETED
Last Update Posted:
2011-01-11
First Post:
2005-12-21
Brief Title:
IMPACT Study Improving Measurements of Persistence on ACtonel Treatment
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
A Multicenter Prospective Study to Assess the Impact of Physicians Reinforcement on the Subjects Compliance and Persistence on Treatment Using Feedback on Bone Markers in Previously Undiagnosed Postmenopausal Osteoporotic Women Treated With Risedronate
Status:
COMPLETED
Status Verified Date:
2011-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective of this study is to assess the impact of physicians reinforcement using bone marker data on the subjects compliance at least 50 drug taken and persistence on treatment after one year in postmenopausal osteoporotic women
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None